Longevity Health Holdings, Inc.
XAGE
$0.26
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.17% | 11.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.17% | 11.06% | |||
| Cost of Revenue | 60.46% | 12.48% | |||
| Gross Profit | -84.13% | 9.82% | |||
| SG&A Expenses | -38.19% | 63.29% | |||
| Depreciation & Amortization | -7.98% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.50% | 43.64% | |||
| Operating Income | 33.25% | -52.92% | |||
| Income Before Tax | 30.06% | -43.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.27% | -45.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.27% | -45.70% | |||
| EBIT | 33.25% | -52.92% | |||
| EBITDA | 33.44% | -53.50% | |||
| EPS Basic | 35.41% | -40.63% | |||
| Normalized Basic EPS | 32.91% | -38.44% | |||
| EPS Diluted | 35.41% | -40.63% | |||
| Normalized Diluted EPS | 32.91% | -38.44% | |||
| Average Basic Shares Outstanding | 6.40% | 3.61% | |||
| Average Diluted Shares Outstanding | 6.40% | 3.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||